⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Actin Cytoskeleton in Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-14 — RHOA-ROCK hyperactivation is associated with impaired migratory persistence and an effector-associated phenotype in aged CD8T cells.: [mechanism-plausible] Preclinical CD8+ T-cell experiments link RHOA–ROCK hyperactivation and impaired cofilin-mediated actin depolymerization to defective migration and activation-induced clustering, with in vitro ROCK-inhibitor rescue identifying a cytoskeletal signaling mechanism without establishing organism-level immune rejuvenation or human treatment benefit. [mechanism-plausible] (novelty: 3)
- 2026-07-11 — Cellular viscous properties in senescence: An emerging biophysical perspective and potential biomarker.: 2026 biophysics review on cellular viscous properties in senescence frames cytoskeletal (actin-dominant) remodeling as a determinant of the viscous — not just elastic — cell-mechanical signature that shifts with senescence, tying actin-cytoskeleton aging to a candidate rheological biomarker channel; synthesis, no new primary actin data. [expert-opinion] (novelty: 3)
- 2026-07-14 — Mechanical signals in aging: mechanisms and therapeutic strategies.: 2026 mechanical-signals-in-aging review positions the actin cytoskeleton as a core relay of mechanotransduction whose aging-associated dysregulation feeds senescence programs and is in principle addressable by mechanics-based interventions, reinforcing (without new data) the framing of actin as a mechano-aging node rather than a bystander. [expert-opinion] (novelty: 3)
- 2026-09-24 — The mechanisms and mechanics of aging.: 2026 mechanics-of-aging review embeds actin cytoskeletal decline within a broader ECM–integrin–cytoskeleton–nucleus mechanotransduction axis, framing altered force transmission through actin as a mid-axis relay between stiffened matrix and dysregulated nuclear YAP/TAZ–MRTF signaling — synthesis, no new primary actin data. [mechanism-plausible] (novelty: 3)
- 2026-08-24 — Form and function of actin impacts actin health and aging.: Model-organism study systematically maps that genetic and pharmacologic disruption of actin and actin-binding proteins shortens lifespan and worsens multiple aging hallmarks, while mild actin stabilization with jasplakinolide modestly extends lifespan; complementary human GWAS signal links ACTN3 polymorphisms to age-related gait-speed decline — first perturbation-based lifespan readout for the actin axis plus a human polymorphism tie, moving the page beyond review-level inference and one ASAP3 KO. [animal-model] (novelty: 3)
- 2026-07-10 — ASAP3 deficiency alleviates hepatic senescence and correlates with extended healthspan in mice.: Mouse Asap3 knockout study: loss of the ArfGAP ASAP3 restores actin cytoskeleton dynamics in aged hepatocytes and extends lifespan/healthspan, moving actin dysregulation from correlative aging-review territory to a specific genetic-perturbation lifespan readout in mammals. [animal-model] (novelty: 3)
- 2026-07-31 — The Physical Senotype in cellular senescence: Mechanical and physical strategies for senotherapy.: 2026 Physical Senotype review reframes cytoskeletal/mechanical alterations as a defining, potentially targetable feature of senescent cells rather than a bystander of aging, tying actin-cytoskeleton dysregulation directly to a proposed mechanical senotherapy pipeline; synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-08-10 — Alterations of actin in aging.: 2026 review synthesizes progressive actin filament disassembly, aggregation, and mislocalization across model organisms as a cytoskeletal axis of aging, tying altered chaperones, actin-binding proteins, transcription, and PTMs to proteostasis loss, mitochondrial dysfunction, and senescence — framing paper, no new primary data. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
RHOA-ROCK hyperactivation is associated with impaired migratory persistence and an effector-associated phenotype in aged CD8T cells.
14-nov-2026
novelty 3
per-area 3
strengthens
The mechanisms and mechanics of aging.
24-sep-2026
novelty 3
per-area 3
strengthens
Form and function of actin impacts actin health and aging.
24-aug-2026
novelty 3
per-area 3
strengthens
Alterations of actin in aging.
10-aug-2026
novelty 3
per-area 3
strengthens
The Physical Senotype in cellular senescence: Mechanical and physical strategies for senotherapy.
31-jul-2026
novelty 3
per-area 3
strengthens
Epigenetic mechanisms shaping cytoskeleton dynamics in cardiovascular diseases.
20-jul-2026
novelty 2
per-area 3
strengthens
Mechanical signals in aging: mechanisms and therapeutic strategies.
14-jul-2026
novelty 3
per-area 3
strengthens
Identification of Potential Biomarkers Associated with Impaired Fatty Acid Oxidation in Aged Skeletal Muscle Using Bioinformatics and Machine Learning Approaches.
14-jul-2026
novelty 2
per-area 2
strengthens
Cellular viscous properties in senescence: An emerging biophysical perspective and potential biomarker.
11-jul-2026
novelty 3
per-area 3
strengthens
ASAP3 deficiency alleviates hepatic senescence and correlates with extended healthspan in mice.
10-jul-2026
novelty 3
per-area 3
strengthens